Market Research > Industries > Chemicals

Market Research: The Global Specialty Excipient
Market for Oral Solid-Dosage-Form Pharmaceuticals,
2005-2015 Volume II: Brazil

The Global Specialty Excipient Market for Oral Solid-Dosage-Form Pharmaceuticals, 2005-2015 Volume II: Brazil

Published December 2006

View PDF brochure
View fact sheet

This report provides a comprehensive examination of the complex and fragmented global market for oral solid-dosage products. Each regional volume features distinct and detailed analyses of five major specialty excipient categories and more than 25 individual products. Key industry dynamics and trends are also examined in each volume. Detailed assessments of specialty excipient procurement practices and business profiles of leading and niche specialty excipient and delivery technology suppliers are provided for each region. A forecast to 2015 completes each regional volume. (Y611C)

	ORDER ONLINE

You may submit an online request to subscribe to sections of this report, using a simple three-step process. After submitting your online request, you will then be contacted by a member of our global sales team to confirm the final price, and complete the transaction. Upon acceptance of your order, we will deliver the files in pdf format via email.

STEP 1 of 3

– Select the sections in which you are interested by clicking on the appropriate boxes:

FULL REPORT [US$ 20 625 (twenty thousand six hundred twenty five US Dollars)]

INTRODUCTION [US$ 0]

Table 1-1 SELECTED SPECIALTY EXCIPIENTS COVERED IN THIS STUDY BY PRODUCT CLASS, 2005
Table 1-2 COMMON ABBREVIATIONS AND ACRONYMS USED IN THIS REPORT

PHARMACEUTICAL INDUSTRY OVERVIEW [US$ 2 500]

Figure 3-1 ESTIMATED SALES OF PHARMACEUTICAL PRODUCTS IN BRAZIL, 1997 TO 2005
Table 3-1 ESTIMATED SALES OF PHARMACEUTICAL PRODUCTS IN BRAZIL BY MARKET SEGMENT, 2005
Table 3-2 LIST OF SELECTED MAJOR PRESCRIPTION THERAPEUTIC CLASSES AND ASSOCIATED MEDICAL CONDITIONS, 2005
Table 3-3 LIST OF SELECTED MAJOR NONPRESCRIPTION DRUG CLASSES AND CATEGORIES WITH ASSOCIATED MEDICAL CONDITIONS, 2005
Ta
Table 3-5 ESTIMATED MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS IN BRAZIL BY PRODUCT CLASS, 2005
Table 3-6 ESTIMATED MANUFACTURERS’ SALES OF NONPRESCRIPTION OSDF PHARMACEUTICALS IN BRAZIL BY PRODUCT CLASS, 2005
Table 3-7 ESTIMATED MANUFACTURERS’ SALES OF THE TOP 10 PRODUCERS OF OTC DRUGS IN BRAZIL, 2005
Table 3-8 LIST OF LEADING NONPRESCRIPTION OSDF PRODUCTS FROM THE TOP 10 OTC COMPANIES IN BRAZIL, 2005
Table 3-9 ESTIMATED MANUFACTURERS’ SALES OF GENERIC AND PRIVATE-LABEL DRUGS IN BRAZIL, 2005

SPECIALTY BINDERS AND FILLERS [US$ 6 200]

Table 4-1 ESTIMATED CONSUMPTION OF SPECIALTY BINDERS AND FILLERS IN BRAZIL BY PRODUCT TYPE, 2005
Table 4-5 FORECAST CONSUMPTION OF SPECIALTY BINDERS AND FILLERS FOR OSDF PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005 TO 2010
Table 4-2 LIST OF PRODUCT TYPES SUPPLIED BY MANUFACTURERS OF SPECIALTY BINDERS AND FILLERS TO THE OSDF PHARMACEUTICAL MARKET IN BRAZIL, 2005
Table 4-3 ESTIMATED VOLUME SALES OF SPECIALTY BINDERS AND FILLERS TO THE OSDF PHARMACEUTICAL MARKET IN BRAZIL BY SUPPLIER AND PRODUCT TYPE, 2005
Table 4-4 ESTIMATED VALUE SALES OF SPECIALTY BINDERS AND FILLERS TO THE OSDF PHARMACEUTICAL MARKET IN BRAZIL BY SUPPLIER AND PRODUCT TYPE, 2005

ALGINATES [US$ 600]

Table 4A-1 LIST OF SELECTED ALGINATE PRODUCTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL
Table 4A-2 ESTIMATED SALES OF ALGINATE PRODUCTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER, 2005

CELLULOSICS [US$ 2 000]

Table 4B-1 ESTIMATED CONSUMPTION OF CELLULOSE ETHERS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005
Table 4B-2 LIST OF CELLULOSE ETHERS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER AND PRODUCT TYPE, 2005
Table 4B-3 ESTIMATED VOLUME SALES OF CELLULOSIC PRODUCTS FOR PHARMACEUTICAL APPLICATIONS BY SUPPLIER, 2005
Table 4B-4 ESTIMATED VALUE SALES OF CELLULOSIC PRODUCTS FOR PHARMACEUTICAL APPLICATIONS BY SUPPLIER, 2005
Table 4B-5 FORECAST CONSUMPTION OF CELLULOSE ETHERS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005 AND 2010

CARBOXYMETHYLCELLULOSE SODIUM [US$ 600]

Table 4B-6 ESTIMATED SALES OF CARBOXYMETHYLCELLULOSE SODIUM FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER, 2005

ETHYL CELLULOSE [US$ 600]

Table 4B-7 ESTIMATED SALES OF ETHYL CELLULOSE PRODUCTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER, 2005

HYDOROXYPROPYL CELLULOSE [US$ 400]

Table 4B-8 LIST OF HYDROXYPROPYLCELLULOSE PRODUCTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL, 2005

HYDROXYPROPYL METHYLCELLULOSE [US$ 600]

Table 4B-9 ESTIMATED SALES OF HYDROXYPROPYL METHYLCELLULOSE PRODUCTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER, 2005

METHYLCELLULOSE [US$ 400]

MICROCRYSTALLINE CELLULOSE [US$ 600]

Table 4B-10 ESTIMATED SALES OF MICROCRYSTALLINE CELLULOSE PRODUCTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER, 2005

DICALCIUM PHOSPHATE [US$ 600]

Table 4C-1 ESTIMATED SALES OF DICALCIUM PHOSPHATE PRODUCTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER

DIRECTLY COMPRESSIBLE SUCROSE [US$ 600]

Table 4D-1 ESTIMATED SALES OF DIRECTLY COMPRESSIBLE SUCROSE PRODUCTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER, 2005

LACTOSE [US$ 600]

Table 4E-1 LIST OF SELECTED LACTOSE PRODUCTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER AND PRODUCT TYPE
Table 4E-2 ESTIMATED SALES OF LACTOSE FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER, 2005

POLYOLS [US$ 1 100]

Table 4F-1 ESTIMATED CONSUMPTION OF POLYOLS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005
Table 4F-2 ESTIMATED SALES OF POLYOL PRODUCTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER, 2005
Table 4F-3 FORECAST CONSUMPTION OF POLYOLS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005 TO 2010

MANNITOL [US$ 600]

Table 4F-4 ESTIMATED SALES OF MANNITOL FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER, 2005

SORBITOL [US$ 600]

Table 4F-5 ESTIMATED SALES OF SORBITOL FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER, 2005

POVIDONE [US$ 600]

Table 4G-1 ESTIMATED SALES OF POVIDONE FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER, 2005

STARCHES [US$ 600]

Table 4H-1 LIST OF SELECTED STARCH PRODUCTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL
Table 4H-5 FORECAST CONSUMPTION OF STARCHES FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005 AND 2010

XANTHAN GUM [US$ 600]

Table 4I-1 ESTIMATED SALES OF XANTHAN GUM FOR PHARMACEUTICAL APPLICATIONS BY SUPPLIER, 2005

DISINTEGRANTS [US$ 2 500]

Table 5-1 ESTIMATED CONSUMPTION OF DISINTEGRANTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005
Table 5-2 ESTIMATED SALES OF DISINTEGRANT PRODUCTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER, 2005
Table 5-3 FORECAST CONSUMPTION OF DISINTEGRANTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005 AND 2010

CROSPOVIDONE [US$ 1 000]

CROSCARMELLOSE SODIUM [US$ 1 000]

SODIUM STARCH GLYCOLATE [US$ 1 000]

LUBRICANTS: MAGNESIUM STEARATE [US$ 2 100]

COATINGS [US$ 3 100]

Table 7-1 LIST OF POLYMER FILM FORMERS USED AS COATINGS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER AND PRODUCT TYPE
Table 7 2 ESTIMATED CONSUMPTION OF FORMULATED COATINGS AND POLYMERS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE
Table 7-3 ESTIMATED SALES OF FORMULATED COATINGS FOR PHARMACEUTICAL APPLICATIONS BY SUPPLIERS IN BRAZIL
Table 7-4 FORECAST CONSUMPTION OF FORMULATED COATINGS AND POLYMERS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005 TO 2010

POLYMERS/FILM FORMERS [US$ 2 000]

Table 7A-1 LIST OF SELECTED POLYMERS FOR PHARMACEUTICAL COATING APPLICATIONS IN BRAZIL
Table 7A-2 LIST OF SELECTED POLYMER PRODUCTS FOR PHARMACEUTICAL COATINGS IN BRAZIL
Table 7A-3 ESTIMATED CONSUMPTION OF POLYMERS FOR PHARMACEUTICAL COATINGS IN BRAZIL BY PRODUCT TYPE, 2005
Table 7A-4 ESTIMATED CONSUMPTION OF POLYMERS FOR PHARMACEUTICAL COATINGS IN BRAZIL BY PRODUCT TYPE AND SEGMENT, 2005
Table 7A-5 ESTIMATED SALES OF POLYMERS FOR PHARMACEUTICAL COATINGS IN BRAZIL BY SUPPLIER, 2005
Table 7A-6 FORECAST CONSUMPTION OF POLYMERS FOR PHARMACEUTICAL COATINGS IN BRAZIL BY PRODUCT TYPE, 2005 TO 2010

POLYMETHACRYLATES [US$ 600]

Table 7A-7 LIST OF SELECTED POLYMETHACRYLATES FOR PHARMACEUTICAL COATING APPLICATIONS IN BRAZIL
Table 7A-8 ESTIMATED CONSUMPTION OF POLYMETHACRYLATES FOR PHARMACEUTICAL COATINGS IN BRAZIL, 2005
Table 7A-9 ESTIMATED SALES OF POLYMETHACRYLATE FOR PHARMACEUTICAL COATINGS IN BRAZIL BY SUPPLIER, 2005

HYDROXYPROPYL METHYLCELLULOSE [US$ 600]

Table 7A-10 ESTIMATED CONSUMPTION OF HPMC FOR OSDF PHARMACEUTICALS IN BRAZIL BY APPLICATION, 2005
Table 7A-11 ESTIMATED SALES OF HPMC FOR PHARMACEUTICAL COATINGS IN BRAZIL BY SUPPLIER, 2005

ETHYL CELLULOSE [US$ 600]

Table 7A-12 ESTIMATED SALES OF EC FOR PHARMACEUTICAL COATINGS IN BRAZIL BY SUPPLIER, 2005

CELLULOSE ACETATE PHTHALATE [US$ 600]

FORMULATED COATINGS [US$ 500]

Table 7B-1 ESTIMATED CONSUMPTION OF FORMULATED PHARMACEUTICAL COATINGS IN BRAZIL, 2005

COATING TYPES [US$ 500]

Table 7C-1 LIST OF SELECTED POLYMERS USED FOR PHARMACEUTICAL COATING APPLICATIONS
Table 7C-2 LIST OF POLYMERS FOR FILM COATING APPLICATIONS IN BRAZIL BY SUPPLIER AND PRODUCT TYPE
Figure 7C-1 FACTORS INFLUENCING THE SUGAR-COATING PROCESS
Figure 7C-2 LAYERING COMBINATIONS FOR SUGAR-COATING APPLICATIONS
Figure 7C-3 SELECTED RAW MATERIALS FOR SUGAR COATINGS BY COATING CATEGORY

COATING FUNCTIONS [US$ 600]

Table 7D-1 LIST OF SELECTED ENTERIC POLYMERS USED FOR PHARMACEUTICAL COATINGS IN BRAZIL BY SUPPLIER AND PRODUCT TYPE
Table 7D-2 LIST OF SELECTED SUSTAINED-RELEASE POLYMERS USED FOR PHARMACEUTICAL COATINGS IN BRAZIL BY SUPPLIER AND PRODUCT TYPE

AESTHETIC/FINISHING COATINGS [US$ 200]

PROTECTIVE COATINGS [US$ 200]

ENTERIC/DELAYED COATINGS [US$ 200]

SUSTAINED-RELEASE COATINGS [US$ 200]

TECHNOLOGY TRENDS [US$ 2 100]

PROCUREMENT PRACTICES [US$ 2 100]

Table 9-1 SELECTED CRITERIA RELATING TO SELECTION OF A SPECIALTY EXCIPIENT

REGULATORY ISSUES [US$ 2 100]

Figure 10-1 ORGANIZATIONAL STRUCTURE OF THE BRAZILIAN PHARMACOPOEIA
Table 10-1 SUMMARY OF ANVISA’S GUIDANCE FOR INDUSTRY, SCALE-UP, AND POST-APPROVAL CHANGES FOR IMMEDIATE RELEASE ORAL SOLID-DOSAGE FORMS
Figure 10-2 SCHEMATIC FOR THE ELABORATION OF BP MONOGRAPHS

SUPPLIERS [US$ 5 200]

Table 11-1 ESTIMATED VOLUME SALES OF SPECIALTY BINDERS AND FILLERS, DISINTEGRANTS, AND LUBRICANTS FOR ORAL SOLID-DOSAGE-FORM APPLICATIONS IN BRAZIL BY SUPPLIER AND PRODUCT TYPE, 2005
Table 11-2 ESTIMATED VALUE SALES OF SPECIALTY BINDERS AND FILLERS, DISINTEGRANTS, AND LUBRICANTS FOR ORAL SOLID-DOSAGE-FORM APPLICATIONS IN BRAZIL BY SUPPLIER AND PRODUCT TYPE, 2005
Table 11-3 ESTIMATED SALES OF COATINGS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY SUPPLIER, 2005

AQUALON [US$ 600]

Table 11A-1 AQUALON’S ESTIMATED SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005
Table 11A-2 AQUALON’S FORECAST SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005 TO 2010

BASF [US$ 600]

Table 11B-1 LIST OF SELECTED BASF EXCIPIENT PRODUCTS FOR PHARMACEUTICAL APPLICATIONS, 2005
Table 11B-2 BASF’S ESTIMATED SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005
Table 11B-3 BASF’S FORECAST SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005 AND 2010

BLANVER [US$ 600]

Table 11C-1 BLANVER’S ESTIMATED SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005
Table 11C-2 BLANVER’S FORECAST SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005 AND 2010

COLORCON [US$ 600]

Table 11D-1 COLORCON’S ESTIMATED SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005

CORN PRODUCTS [US$ 500]

DOW CHEMICAL [US$ 600]

Table 11F-1 DOW’S ESTIMATED SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005

FMC [US$ 600]

Table 11G-1 FMC’S ESTIMATED SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005
Table 11G-2 FMC’S FORECAST SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005 TO 2010

IPIRANGA QUIMICA/FORLAB [US$ 600]

Table 11H-1 LIST OF SELECTED PHARMACEUTICAL EXCIPIENT PRODUCTS MARKETED BY IPIRANGA QUÍMICA/FORLAB IN BRAZIL
Table 11H-2 IPIRANGA QUÍMICA’S ESTIMATED SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005
Table 11H-3 IPIRANGA QUÍMICA’S FORECAST SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005 TO 2010

ISP [US$ 600]

Table 11I-1 FMC’S ESTIMATED SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005
Table 11I-2 ISP’S FORECAST SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005 TO 2010

J.RETTENMAIER & SOHNE GmbH [US$ 600]

Table 11J-1 LIST OF SELECTED JRS EXCIPIENT PRODUCTS FOR PHARMACEUTICAL APPLICATIONS, 2005
Table 11J-2 JRS’S ESTIMATED SALES OF EXCIPIENTS FOR PHARMACEUTICAL APPLICATIONS IN BRAZIL BY PRODUCT TYPE, 2005

STEP 2 of 3

– Provide your contact information:

All fields in *BOLD are required.

*Name:
*Title:
*Company/Division:
*Address 1 :
Address 2 :
*City:
*State/Province:
*Zip/Postal code:
*Country:
*Phone:
Fax:
*Email:

STEP 3 of 3

– Review and accept our subscription terms and conditions by viewing and clicking below:

*Please view our terms and conditions, and check this box to indicate your acceptance of these terms and conditions.

Thank you for your interest in subscribing to our syndicated reports. To complete this process, please click on the button below and a member of our global sales team will contact you shortly to confirm the final price and complete the transaction. Upon acceptance of your order, we will deliver the files in PDF format via email.

Market Research: The Global Specialty Excipient Market for Oral Solid-Dosage-Form Pharmaceuticals, 2005-2015 Volume II: Brazil

The Global Specialty Excipient Market for Oral Solid-Dosage-Form Pharmaceuticals, 2005-2015 Volume II: Brazil

ORDER ONLINE

STEP 1 of 3

STEP 2 of 3

STEP 3 of 3

Questions?

Market Research: The Global Specialty Excipient
Market for Oral Solid-Dosage-Form Pharmaceuticals,
2005-2015 Volume II: Brazil